Frontiers in Cardiovascular Medicine | Lipids in Cardiovascular Disease

Original Research

Published on 17 Oct 2022

Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents

in Lipids in Cardiovascular Disease

Shuai Wang
Di Fu
Huixing Liu
Daoquan Peng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.934914

2,447 views
9 citations

Original Research

Published on 12 Oct 2022

Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity

in Lipids in Cardiovascular Disease

Michele Mietus-Snyder
William Suslovic
Meghan Delaney
Martin P. Playford
Rami A. Ballout
John R. Barber
James D. Otvos
Roberta L. DeBiasi
Nehal N. Mehta
Alan T. Remaley

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1033660

2,861 views
10 citations

Case Report

Published on 12 Oct 2022

Chylomicronemia through a burr hole: A case report

in Lipids in Cardiovascular Disease

Wann Jia Loh
Ramesh Bakthavachalam
Tavintharan Subramaniam
Sharon Pek
Fionn Chua
Lester Lee
Gerald F. Watts

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1020397

1,983 views
2 citations

Original Research

Published on 06 Oct 2022

Comparison between distinct insulin resistance indices in measuring the development of hypertension: The China Health and Nutrition Survey

in Lipids in Cardiovascular Disease

Yue Yuan
Wei Sun
Xiangqing Kong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.912197

3,096 views
19 citations

Review

Published on 04 Oct 2022

Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights

in Lipids in Cardiovascular Disease

Hsiang-Chun Lee
Alexander Akhmedov
Chu-Huang Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.993633

9,625 views
17 citations

Systematic Review

Published on 30 Sep 2022

Red meat consumption and risk for dyslipidaemia and inflammation: A systematic review and meta-analysis

in Lipids in Cardiovascular Disease

Le Sun
Jia-Lin Yuan
Qiu-Cen Chen
Wen-Kang Xiao
Gui-Ping Ma
Jia-Hua Liang
Xiao-Kun Chen
Song Wang
Xiao-Xiong Zhou
Hui Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.996467

25,272 views
19 citations

Original Research

Published on 20 Sep 2022

Remnant cholesterol is associated with cardiovascular mortality

in Lipids in Cardiovascular Disease

Kerui Zhang
Xiangyun Qi
Fuyu Zhu
Quanbin Dong
Zhongshan Gou
Fang Wang
Li Xiao
Menghuan Li
Lianmin Chen
Yifeng Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.984711

7,220 views
22 citations

Perspective

Published on 15 Sep 2022

The rationale for the treatment of long-Covid symptoms – A cardiologist's view

in Lipids in Cardiovascular Disease

Elisabeth Schieffer
Bernhard Schieffer

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.992686

37,850 views
7 citations

Brief Research Report

Published on 13 Sep 2022

Increased atherosclerotic plaque in AOC3 knock-out in ApoE−/− mice and characterization of AOC3 in atherosclerotic human coronary arteries

in Lipids in Cardiovascular Disease

Anna Filip
Soraya Taleb
Rümeyza Bascetin
Mohammad Jahangiri
Matthieu Bardin
Cindy Lerognon
Bruno Fève
Patrick Lacolley
Sirpa Jalkanen
Nathalie Mercier

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.848680

3,413 views
3 citations

Review

Published on 08 Sep 2022

Targets of statins intervention in LDL-C metabolism: Gut microbiota

in Lipids in Cardiovascular Disease

ChangXin Sun
ZePing Wang
LanQing Hu
XiaoNan Zhang
JiYe Chen
ZongLiang Yu
LongTao Liu
Min Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.972603

8,832 views
13 citations

Systematic Review

Published on 07 Sep 2022

Effect of 9p21.3 (lncRNA and CDKN2A/2B) variant on lipid profile

in Lipids in Cardiovascular Disease

Baozhu Wei
Yang Liu
Hang Li
Yuanyuan Peng
Zhi Luo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.946289

2,548 views
9 citations

Review

Published on 31 Aug 2022

Sphingolipid metabolism and signaling in cardiovascular diseases

in Lipids in Cardiovascular Disease

Sonia Borodzicz-Jażdżyk
Piotr Jażdżyk
Wojciech Łysik
Agnieszka Cudnoch-Jȩdrzejewska
Katarzyna Czarzasta

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.915961

7,508 views
31 citations

Original Research

Published on 30 Aug 2022

Association of remnant cholesterol and lipid parameters with new-onset carotid plaque in Chinese population

in Lipids in Cardiovascular Disease

Bo Liu
Fangfang Fan
Bo Zheng
Ying Yang
Jia Jia
Pengfei Sun
Yimeng Jiang
Kaiyin Li
Jiahui Liu
Chuyun Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.903390

2,833 views
12 citations

Mini Review

Published on 29 Aug 2022

Pinocytotic engulfment of lipoproteins by macrophages

in Lipids in Cardiovascular Disease

Takuro Miyazaki

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.957897

3,987 views
4 citations

Mini Review

Published on 25 Aug 2022

Physical activity to reduce PCSK9 levels

in Lipids in Cardiovascular Disease

Amedeo Tirandi
Fabrizio Montecucco
Luca Liberale

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.988698

3,921 views
3 citations

Original Research

Published on 22 Aug 2022

Isoprenaline modified the lipidomic profile and reduced β-oxidation in HL-1 cardiomyocytes: In vitro model of takotsubo syndrome

in Lipids in Cardiovascular Disease

Ivana Fiserova
Minh Duc Trinh
Moustafa Elkalaf
Lukas Vacek
Marek Heide
Stanislava Martinkova
Kamila Bechynska
Vit Kosek
Jana Hajslova
Ondrej Fiser

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.917989

4,575 views
5 citations